logo

Corvis Corp (CORV)



Trade CORV now with
  Date
  Headline
11/4/2019 7:15:00 AM Correvio Announces FDA Advisory Committee Meeting To Review Brinavess For Recent Onset Atrial Fibrillation
9/3/2019 8:03:28 AM Correvio Announces Presentation Of Brinavess® Spectrum Data
8/14/2019 7:13:30 AM Correvio Q2 Net Loss $10.5 Mln Or $0.26/Shr Vs Net Income $5.4 Mln Or $0.16/Shr Prior Year
8/14/2019 7:12:03 AM Correvio Q2 Net Loss $10.5 Mln Or $0.26/Shr Vs Income Of $5.4 Mln Or $0.16/Shr Last Year
8/7/2019 9:28:54 AM Correvio Closes Public Offering Of 9.20 Mln Common Shares
8/2/2019 9:16:24 AM Correvio Pharma Prices Underwritten Public Offering Of 8 Mln Shares At US$1.50/shr
7/25/2019 7:19:22 AM Correvio Pharma Says US FDA Accepts Its Resubmitted New Drug Application For Brinavess
6/24/2019 7:01:54 AM Correvio Resubmits Brinavess NDA To FDA For Treatment Of Patients With Recent Onset Atrial Fibrillation
5/8/2019 8:04:46 AM Correvio Q1 Net Loss $9.0 Mln Or $0.23/Shr Vs Net Loss Of $8.5 Mln Or $0.24/Shr Last Year
4/3/2019 9:29:44 AM Correvio Announces Xydalba Abstracts At ECCMID 2019
3/14/2019 7:05:27 AM Correvio Pharma Announces At The Market Offering
3/13/2019 7:04:08 AM Correvio Pharma Q4 Net Loss $6.4 Mln Or $0.18 /Shr Vs Loss Of $8.3 Mln Or $0.24/Shr Last Year
1/2/2019 8:07:11 AM Correvio Pharma Names Mark Corrigan Next CEO To Succeed William Hunter
1/2/2019 8:05:01 AM Correvio : Mark H.N. Corrigan To Succeed William Hunter, As CEO By End Of Q1 2019
9/5/2018 7:08:18 AM Correvio Pharma Reports Preliminary Data From SPECTRUM Study
  
 
>